Caulkins JP. Changes in self-reported cannabis use in the United States from 1979 to 2022. Addiction. 2024;119:1648–52.
Carlini BH, Schauer GL. Cannabis-only use in the USA: prevalence, demographics, use patterns, and health indicators. J Cannabis Res. 2022;4:39.
Mattingly DT, Richardson MK, Hart JL. Prevalence of and trends in current cannabis use among US youth and adults, 2013-2022. Drug Alc Depend Rep. 2024;12:100253.
European Monitoring Centre of Drugs and Drug Addiction. European Drug Report: Trend and Developments. 2022. https://www.emcdda.europa.eu/system/files/publications/14644/EDR_2022_18-ONLINE.pdf.
Patrick ME, Miech RA, Johnston LD, and O’Malley PM. Monitoring the Future Monograph Series. Ann Arbor, MI: University of Michigan, Institute for Social Research; 2024.
Benedetti E, Resce G, Brunori P, Molinaro S. Cannabis policy changes and adolescent cannabis use: evidence from Europe. Int J Env Res Pub He. 2021;18:5174.
Chiu V, Leung J, Hall W, Stjepanovic D, Degenhardt L. Public health impacts to date of the legalisation of medical and recreational cannabis use in the USA. Neuropharmacology. 2021;193:108610.
Cox C. The Canadian Cannabis Act legalizes and regulates recreational cannabis use in 2018. Health Policy. 2022;126:722–22.
Durán-Martínez A, Pennell C. Change from above or pressure from below? The Diffusion of Cannabis Reform in Latin America. B Lat Am Res. 2024;43:347–61.
Ren M, Tang Z, Wu X, Spengler R, Jiang H, Yang Y, et al. The origins of cannabis smoking: Chemical residue evidence from the first millennium BCE in the Pamirs. Sci Adv. 2019;5:eaaw1391.
Trezza V, Cuomo V, Vanderschuren LJ. Cannabis and the developing brain: insights from behavior. Eur J Pharm. 2008;585:441–52.
Battistella G, Fornari E, Annoni JM, Chtioui H, Dao K, Fabritius M, et al. Long-term effects of cannabis on brain structure. Neuropsychopharmacology. 2014;39:2041–8.
Burggren AC, Shirazi A, Ginder N, London ED. Cannabis effects on brain structure, function, and cognition: considerations for medical uses of cannabis and its derivatives. Am J Drug Alcohol Abus. 2019;45:563–79.
Pasman JA, Verweij KJH, Gerring Z, Stringer S, Sanchez-Roige S, Treur JL, et al. GWAS of lifetime cannabis use reveals new risk loci, genetic overlap with psychiatric traits, and a causal influence of schizophrenia. Nat Neurosci. 2018;21:1161–70.
Stringer S, Minica CC, Verweij KJ, Mbarek H, Bernard M, Derringer J, et al. Genome-wide association study of lifetime cannabis use based on a large meta-analytic sample of 32 330 subjects from the International Cannabis Consortium. Transl Psychiatry. 2016;6:e769.
Thorpe HHA, Fontanillas P, Meredith JJ, Jennings MV, Cupertino RB, Pakala S, et al. Genome-wide association studies of lifetime and frequency cannabis use in 131,895 individuals. medRxiv. 2024; https://www.medrxiv.org/content/10.1101/2024.06.14.24308946v1.
Levey DF, Galimberti M, Deak JD, Wendt FR, Bhattacharya A, Koller D, et al. Multi-ancestry genome-wide association study of cannabis use disorder yields insight into disease biology and public health implications. Nat Genet. 2023;55:2094–103.
Arends RM, Pasman JA, Verweij KJH, Derks EM, Gordon SD, Hickie I, et al. Associations between the CADM2 gene, substance use, risky sexual behavior, and self-control: A phenome-wide association study. Addict Biol. 2021;26:e13015.
Zhou H, Sealock JM, Sanchez-Roige S, Clarke TK, Levey DF, Cheng Z, et al. Genome-wide meta-analysis of problematic alcohol use in 435,563 individuals yields insights into biology and relationships with other traits. Nat Neurosci. 2020;23:809–18.
Karlsson Linner R, Biroli P, Kong E, Meddens SFW, Wedow R, Fontana MA, et al. Genome-wide association analyses of risk tolerance and risky behaviors in over 1 million individuals identify hundreds of loci and shared genetic influences. Nat Genet. 2019;51:245–57.
Sanchez-Roige S, Jennings MV, Thorpe HHA, Mallari JE, van der Werf LC, Bianchi SB, et al. CADM2 is implicated in impulsive personality and numerous other traits by genome- and phenome-wide association studies in humans and mice. Translational Psychiatry. 2023;13:167.
Galimberti M, Levey DF, Deak JD, Zhou H, Stein MB, Gelernter J. Genetic influences and causal pathways shared between cannabis use disorder and other substance use traits. Mol Psychiatry. 2024;29:2905–10.
Saunders GRB, Wang X, Chen F, Jang SK, Liu M, Wang C, et al. Genetic diversity fuels gene discovery for tobacco and alcohol use. Nature. 2022;612:720–24.
All of Us Research Program I, Denny JC, Rutter JL, Goldstein DB, Philippakis A, Smoller JW, et al. The “All of Us” Research Program. N Engl J Med. 2019;381:668–76.
Bick AG, Metcall GA, Mayo KR, Lichtenstein L, Rura S, Carroll RJ, et al. Genomic data in the All of Us Research Program. Nature. 2024;627:340–6.
Willer CJ, Li Y, Abecasis GR. METAL: fast and efficient meta-analysis of genomewide association scans. Bioinformatics. 2010;26:2190–91.
Turner S qqman: an R package for visualizing GWAS results using Q-Q. The Journal of Open Source Software. 2018;1:731.
de Leeuw CA, Mooij JM, Heskes T, Posthuma D. MAGMA: generalized gene-set analysis of GWAS data. PLoS Comput Biol. 2015;11:e1004219.
Watanabe K, Taskesen E, van Bochoven A, Posthuma D. Functional mapping and annotation of genetic associations with FUMA. Nat Commun. 2017;8:1826.
Genomes Project C, Auton A, Brooks LD, Durbin RM, Garrison EP, Kang HM, et al. A global reference for human genetic variation. Nature. 2015;526:68–74.
Konrad J Karczewski RG, Kanai M, Lu W, Tsuo K, Wang Y, Walters RK, Turley P, et al. Pan-UK Biobank GWAS improves discovery, analysis of genetic architecture, and resolution into ancestry-enriched effects. medRxiv 2024;03.13.24303864.
Austin-Zimmerman I, Levey DF, Giannakopoulou O, Deak JD, Galimberti M, Adhikari K, et al. Genome-wide association studies and cross-population meta-analyses investigating short and long sleep duration. Nat Commun. 2023;14:6059.
Watanabe K, Jansen PR, Savage JE, Nandakumar P, Wang X, Me Research T, et al. Genome-wide meta-analysis of insomnia prioritizes genes associated with metabolic and psychiatric pathways. Nat Genet. 2022;54:1125–32.
Hancock DB, Guo Y, Reginsson GW, Gaddis NC, Lutz SM, Sherva R, et al. Genome-wide association study across European and African American ancestries identifies a SNP in DNMT3B contributing to nicotine dependence. Mol Psychiatry. 2018;23:1911–19.
Deak JD, Zhou H, Galimberti M, Levey DF, Wendt FR, Sanchez-Roige S, et al. Genome-wide association study in individuals of European and African ancestry and multi-trait analysis of opioid use disorder identifies 19 independent genome-wide significant risk loci. Mol Psychiatry. 2022;27:3970–79.
Gupta P, Galimberti M, Liu Y, Beck S, Wingo A, Wingo T, et al. A genome-wide investigation into the underlying genetic architecture of personality traits and overlap with psychopathology. Nat Hum Behav. 2024;8:2235–49.
Hatoum AS, Morrison CL, Mitchell EC, Lam M, Benca-Bachman CE, Reineberg AE, et al. Genome-wide Association Study shows that executive functioning is influenced by GABAergic processes and is a neurocognitive genetic correlate of psychiatric disorders. Biol Psychiatry. 2023;93:59–70.
Wightman DP, Jansen IE, Savage JE, Shadrin AA, Bahrami S, Holland D, et al. A genome-wide association study with 1,126,563 individuals identifies new risk loci for Alzheimer’s disease. Nat Genet. 2021;53:1276–82.
Trubetskoy V, Pardinas AF, Qi T, Panagiotaropoulou G, Awasthi S, Bigdeli TB, et al. Mapping genomic loci implicates genes and synaptic biology in schizophrenia. Nature. 2022;604:502–08.
Levey DF, Stein MB, Wendt FR, Pathak GA, Zhou H, Aslan M, et al. Bi-ancestral depression GWAS in the Million Veteran Program and meta-analysis in >1.2 million individuals highlight new therapeutic directions. Nat Neurosci. 2021;24:954–63.
Zhang H, Ahearn TU, Lecarpentier J, Barnes D, Beesley J, Qi G, et al. Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses. Nat Genet. 2020;52:572–81.
Kurki MI, Karjalainen J, Palta P, Sipila TP, Kristiansson K, Donner KM, et al. FinnGen provides genetic insights from a well-phenotyped isolated population. Nature. 2023;613:508–18.
Preuss M, Konig IR, Thompson JR, Erdmann J, Absher D, Assimes TL, et al. Design of the Coronary ARtery DIsease Genome-Wide Replication And Meta-Analysis (CARDIoGRAM) Study: a genome-wide association meta-analysis involving more than 22 000 cases and 60 000 controls. Circ Cardiovasc Genet. 2010;3:475–83.
Shah S, Henry A, Roselli C, Lin H, Sveinbjornsson G, Fatemifar G, et al. Genome-wide association and Mendelian randomisation analysis provide insights into the pathogenesis of heart failure. Nat Commun. 2020;11:163.
Surakka I, Wu KH, Hornsby W, Wolford BN, Shen F, Zhou W, et al. Multi-ancestry meta-analysis identifies 5 novel loci for ischemic stroke and reveals heterogeneity of effects between sexes and ancestries. Cell Genom. 2023;3:100345.
Smith SM, Douaud G, Chen W, Hanayik T, Alfaro-Almagro F, Sharp K, et al. An expanded set of genome-wide association studies of brain imaging phenotypes in UK Biobank. Nat Neurosci. 2021;24:737–45.
Brown BC, Ye CJ, Price AL, Zaitlen N. Network AGE. Transethnic Genetic-Correlation Estimates from Summary Statistics. Am J Hum Genet. 2016;99:76–88.
Werme J, van der Sluis S, Posthuma D, de Leeuw CA. An integrated framework for local genetic correlation analysis. Nat Genet. 2022;54:274–82.
Mounier N, Kutalik Z. Bias correction for inverse variance weighting Mendelian randomization. Genet Epidemiol. 2023;47:314–31.
Hemani G, Tilling K, Davey Smith G. Orienting the causal relationship between imprecisely measured traits using GWAS summary data. PLoS Genet. 2017;13:e1007081.
Consortium GT. The GTEx Consortium atlas of genetic regulatory effects across human tissues. Science. 2020;369:1318–30.
Gusev A, Ko A, Shi H, Bhatia G, Chung W, Penninx BW, et al. Integrative approaches for large-scale transcriptome-wide association studies. Nat Genet. 2016;48:245–52.
Mancuso N, Freund MK, Johnson R, Shi H, Kichaev G, Gusev A, et al. Probabilistic fine-mapping of transcriptome-wide association studies. Nat Genet. 2019;51:675–82.
Ge T, Chen CY, Ni Y, Feng YA, Smoller JW. Polygenic prediction via Bayesian regression and continuous shrinkage priors. Nat Commun. 2019;10:1776.
Bright U, Overstreet C, Levey DF, Gelernter J. Differences and similarities between the genetic architecture of lifetime substance use across different substances. Psychol Med. 2025;55:e219.
Moulton EA, Elman I, Becerra LR, Goldstein RZ, Borsook D. The cerebellum and addiction: insights gained from neuroimaging research. Addict Biol. 2014;19:317–31.
Alexander WH, Fukunaga R, Finn P, Brown JW. Reward salience and risk aversion underlie differential ACC activity in substance dependence. Neuroimage Clin. 2015;8:59–71.
Yan X, Wang Z, Schmidt V, Gauert A, Willnow TE, Heinig M, et al. Cadm2 regulates body weight and energy homeostasis in mice. Mol Metab. 2018;8:180–88.
Ibrahim O, Sutherland HG, Avgan N, Spriggens LK, Lea RA, Haupt LM, et al. Investigation of the CADM2 polymorphism rs17518584 in memory and executive functions measures in a cohort of young healthy individuals. Neurobiol Learn Mem. 2018;155:330–36.
Zhang YT, Zhao LJ, Zhou T, Zhao JY, Geng YP, Zhang QR, et al. The lncRNA CADM2-AS1 promotes gastric cancer metastasis by binding with miR-5047 and activating NOTCH4 translation. Front Pharm. 2024;15:1439497.
Pizzol D, Demurtas J, Stubbs B, Soysal P, Mason C, Isik AT, et al. Relationship between cannabis use and erectile dysfunction: a systematic review and meta-analysis. Am J Mens Health. 2019;13:1557988319892464.
Gelernter J, Yu Y, Weiss R, Brady K, Panhuysen C, Yang BZ, et al. Haplotype spanning TTC12 and ANKK1, flanked by the DRD2 and NCAM1 loci, is strongly associated to nicotine dependence in two distinct American populations. Hum Mol Genet. 2006;15:3498–507.
Yang BZ, Kranzler HR, Zhao H, Gruen JR, Luo X, Gelernter J. Association of haplotypic variants in DRD2, ANKK1, TTC12 and NCAM1 to alcohol dependence in independent case control and family samples. Hum Mol Genet. 2007;16:2844–53.
Xu H, Toikumo S, Crist RC, Glogowska K, Jinwala Z, Deak JD, et al. Identifying genetic loci and phenomic associations of substance use traits: a multi-trait analysis of GWAS (MTAG) study. Addiction. 2023;118:1942–52.
Song W, Lin GN, Yu S, Zhao M. Genome-wide identification of the shared genetic basis of cannabis and cigarette smoking and schizophrenia implicates NCAM1 and neuronal abnormality. Psychiatry Res. 2022;310:114453.
Wang C, Chen A, Ruan B, Niu Z, Su Y, Qin H, et al. PCDH7 inhibits the formation of homotypic cell-in-cell structure. Front Cell Dev Biol. 2020;8:329.
Zhang S, Fu X. The clinical significance and biological function of PCDH7 in cervical cancer. Cancer Manag Res. 2021;13:3841–47.
de Wit J, Sylwestrak E, O’Sullivan ML, Otto S, Tiglio K, Savas JN, et al. LRRTM2 interacts with Neurexin1 and regulates excitatory synapse formation. Neuron. 2009;64:799–806.
Dhume SH, Connor SA, Mills F, Tari PK, Au-Yeung SHM, Karimi B, et al. Distinct but overlapping roles of LRRTM1 and LRRTM2 in developing and mature hippocampal circuits. Elife. 2022;11:e64742.
Bhouri M, Morishita W, Temkin P, Goswami D, Kawabe H, Brose N, et al. Deletion of LRRTM1 and LRRTM2 in adult mice impairs basal AMPA receptor transmission and LTP in hippocampal CA1 pyramidal neurons. Proc Natl Acad Sci USA. 2018;115:E5382–E89.
Hu Z, Xiao X, Zhang Z, Li M. Genetic insights and neurobiological implications from NRXN1 in neuropsychiatric disorders. Mol Psychiatry. 2019;24:1400–14.
Fernando MB, Fan Y, Zhang Y, Tokolyi A, Murphy AN, Kammourh S, et al. Phenotypic complexities of rare heterozygous neurexin-1 deletions. Nature. 2025;642:710–20.
Nussbaum J, Xu Q, Payne TJ, Ma JZ, Huang W, Gelernter J, et al. Significant association of the neurexin-1 gene (NRXN1) with nicotine dependence in European- and African-American smokers. Human Mol Genet. 2008;17:1569–77.
William N, Reissner C, Sargent R, Darlington TM, DiBlasi E, Li QS, et al. Neurexin 1 variants as risk factors for suicide death. Mol Psychiatry. 2021;26:7436–45.
Lamri A, Pigeyre M, Garver WS, Meyre D. The Extending Spectrum of NPC1-Related Human Disorders: From Niemann-Pick C1 Disease to Obesity. Endocr Rev. 2018;39:192–220.
Liu R, Zou Y, Hong J, Cao M, Cui B, Zhang H, et al. Rare Loss-of-Function Variants in NPC1 Predispose to Human Obesity. Diabetes. 2017;66:935–47.
Bonnot O, Gama CS, Mengel E, Pineda M, Vanier MT, Watson L, et al. Psychiatric and neurological symptoms in patients with Niemann-Pick disease type C (NP-C): Findings from the International NPC Registry. World J Biol Psychiatry. 2019;20:310–19.
Ong LT. Psychosis symptoms associated with Niemann-Pick disease type C. Psychiatr Genet. 2021;31:107–18.
Li HJ, Qu N, Hui L, Cai X, Zhang CY, Zhong BL, et al. Further confirmation of netrin 1 receptor (DCC) as a depression risk gene via integrations of multi-omics data. Transl Psychiat. 2020;10:98.
Wang Z, Li P, Wu T, Zhu S, Deng L, Cui G. Axon guidance pathway genes are associated with schizophrenia risk. Exp Ther Med. 2018;16:4519–26.
Washer SJ, Flynn R, Oguro-Ando A, Hannon E, Burrage J, Jeffries A, et al. Functional characterization of the schizophrenia associated gene AS3MT identifies a role in neuronal development. Am J Med Genet B Neuropsychiatr Genet. 2022;189:151–62.
Li M, Jaffe AE, Straub RE, Tao R, Shin JH, Wang Y, et al. A human-specific AS3MT isoform and BORCS7 are molecular risk factors in the 10q24.32 schizophrenia-associated locus. Nat Med. 2016;22:649–56.
Okbay A, Wu Y, Wang N, Jayashankar H, Bennett M, Nehzati SM, et al. Polygenic prediction of educational attainment within and between families from genome-wide association analyses in 3 million individuals. Nat Genet. 2022;54:437–49.
Schoeler T, Pingault JB, Kutalik Z. Combining cross-sectional and longitudinal genomic approaches to identify determinants of cognitive and physical decline. Nat Commun. 2025;16:4524.
Karlsson Linner R, Mallard TT, Barr PB, Sanchez-Roige S, Madole JW, Driver MN, et al. Multivariate analysis of 1.5 million people identifies genetic associations with traits related to self-regulation and addiction. Nat Neurosci. 2021;24:1367–76.
Hatoum AS, Johnson EC, Colbert SMC, Polimanti R, Zhou H, Walters RK, et al. The addiction risk factor: a unitary genetic vulnerability characterizes substance use disorders and their associations with common correlates. Neuropsychopharmacology. 2022;47:1739–45.
Hindocha C, Shaban NDC, Freeman TP, Das RK, Gale G, Schafer G, et al. Associations between cigarette smoking and cannabis dependence: a longitudinal study of young cannabis users in the United Kingdom. Drug Alcohol Depen. 2015;148:165–71.
Koning P, Webbink D, Martin NG. The effect of education on smoking behavior: new evidence from smoking durations of a sample of twins. Empir Econ. 2015;48:1479–97.
Latvala A, Rose RJ, Pulkkinen L, Dick DM, Korhonen T, Kaprio J. Drinking, smoking, and educational achievement: cross-lagged associations from adolescence to adulthood. Drug Alcohol Depen. 2014;137:106–13.
Carliner H, Brown QL, Sarvet AL, Hasin DS. Cannabis use, attitudes, and legal status in the US: a review. Prev Med. 2017;104:13–23.
Silins E, Fergusson DM, Patton GC, Horwood LJ, Olsson CA, Hutchinson DM, et al. Adolescent substance use and educational attainment: an integrative data analysis comparing cannabis and alcohol from three Australasian cohorts. Drug Alcohol Rev. 2015;34:59–60.
Lorenzetti V, Hoch E, Hall W. Adolescent cannabis use, cognition, brain health and educational outcomes: a review of the evidence. Eur Neuropsychopharm. 2020;36:169–80.
Das SK. Harmful health effects of cigarette smoking. Mol Cell Biochem. 2003;253:159–65.
Coelho J, Montagni I, Micoulaud-Franchi JA, Plancoulaine S, Tzourio C. Study of the association between cannabis use and sleep disturbances in a large sample of University students. Psychiatry Res. 2023;322:115096.
Abuhasira R, Haviv YS, Leiba M, Leiba A, Ryvo L, Novack V. Cannabis is associated with blood pressure reduction in older adults-A 24-hours ambulatory blood pressure monitoring study. Eur J Intern Med. 2021;86:79–85.
Alshaarawy O, Elbaz HA. Cannabis use and blood pressure levels: United States National Health and Nutrition Examination Survey, 2005-2012. J Hypertens. 2016;34:1507–12.
Vidot DC, Powers M, Gonzalez R, Jayaweera DT, Roy S, Dong CM, et al. Blood pressure and marijuana use: results from a decade of NHANES data. Am J Health Behav. 2019;43:887–97.
Clarke TK, Adams MJ, Davies G, Howard DM, Hall LS, Padmanabhan S, et al. Genome-wide association study of alcohol consumption and genetic overlap with other health-related traits in UK Biobank (N=112 117). Mol Psychiatry. 2017;22:1376–84.
Kranzler HR, Zhou H, Kember RL, Vickers Smith R, Justice AC, Damrauer S, et al. Genome-wide association study of alcohol consumption and use disorder in 274,424 individuals from multiple populations. Nat Commun. 2019;10:1499.
Verma A, Huffman JE, Rodriguez A, Conery M, Liu M, Ho YL, et al. Diversity and scale: genetic architecture of 2068 traits in the VA Million Veteran Program. Science. 2024;385:eadj1182.